Hurler syndrome medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
== | ==Overview== | ||
Enzyme replacement therapies are currently in use, [[BioMarin Pharmaceutical]] provides therapeutics for mucopolysaccaradosis type I (MPS I), by manufacturing Aldurazyme® (commercialized by [[Genzyme]] Corporation). Enzyme replacement therapy has proven useful in reducing non-neurological symptoms and pain. | Enzyme replacement therapies are currently in use, [[BioMarin Pharmaceutical]] provides therapeutics for mucopolysaccaradosis type I (MPS I), by manufacturing Aldurazyme® (commercialized by [[Genzyme]] Corporation). Enzyme replacement therapy has proven useful in reducing non-neurological symptoms and pain. | ||
| Line 12: | Line 12: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Gastroenterology]] | |||
[[Category:Genetic disorders]] | |||
[[Category:Hepatology]] | |||
[[Category:Syndromes]] | |||
[[Category:Mature chapter]] | |||
[[Category:Metabolic disorders]] | |||
[[Category:Lysosomal storage diseases]] | |||
[[Category:Cardiology]] | |||
[[Category:Psychiatry]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category: | [[Category:Inborn errors of metabolism]] | ||
Revision as of 00:42, 26 February 2013
|
Hurler Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hurler syndrome medical therapy On the Web |
|
American Roentgen Ray Society Images of Hurler syndrome medical therapy |
|
Risk calculators and risk factors for Hurler syndrome medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Enzyme replacement therapies are currently in use, BioMarin Pharmaceutical provides therapeutics for mucopolysaccaradosis type I (MPS I), by manufacturing Aldurazyme® (commercialized by Genzyme Corporation). Enzyme replacement therapy has proven useful in reducing non-neurological symptoms and pain.